Drug Search Results
More Filters [+]

Gaxilose

Alternative Names: gaxilose
Latest Update: 2024-07-31
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Imaging Agent

Novel Mechanism: No

Modality: Diagnostic Agent

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Germany | Portugal | Spain

Approved Indications: None

Known Adverse Events: None

Company: Venter Pharma S.L.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Gaxilose

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Lactose Intolerance

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

VPH-GXL-2022-511

P1

Unknown Status

Healthy Volunteers

2023-06-30

2015-001181-26

P4

Active, not recruiting

Lactose Intolerance

2015-09-07

Recent News Events

Date

Type

Title